(S)-4-(2-methyl-3-phenoxypropoxy)-1-m-tolylpyridin-2(1H)-one

ID: ALA4554871

PubChem CID: 155556417

Max Phase: Preclinical

Molecular Formula: C22H23NO3

Molecular Weight: 349.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(-n2ccc(OC[C@H](C)COc3ccccc3)cc2=O)c1

Standard InChI:  InChI=1S/C22H23NO3/c1-17-7-6-8-19(13-17)23-12-11-21(14-22(23)24)26-16-18(2)15-25-20-9-4-3-5-10-20/h3-14,18H,15-16H2,1-2H3/t18-/m1/s1

Standard InChI Key:  KIHWPJLHBQPIHX-GOSISDBHSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    4.9902  -27.9016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7031  -27.4865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4192  -27.8963    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1320  -27.4810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8439  -27.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5547  -27.4800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5558  -26.6547    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8400  -26.2427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1230  -26.6561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8397  -25.4178    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2703  -26.2422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9815  -26.6579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6955  -26.2461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6959  -25.4203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9765  -25.0079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2653  -25.4221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2742  -27.4919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5612  -27.9070    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8453  -27.4972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4152  -26.6704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4141  -27.4977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1288  -27.9106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8425  -26.6668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1271  -26.2576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9933  -28.7266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9735  -24.1829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  7 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  1 17  1  0
 17 18  1  0
 18 19  1  0
 20 21  2  0
 21 22  1  0
 22 19  2  0
 19 23  1  0
 23 24  2  0
 24 20  1  0
  1 25  1  6
 15 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4554871

    ---

Associated Targets(non-human)

Grm3 Metabotropic glutamate receptor 3 (981 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 349.43Molecular Weight (Monoisotopic): 349.1678AlogP: 4.24#Rotatable Bonds: 7
Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.31CX LogD: 4.31
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.64Np Likeness Score: -0.89

References

1. Yamada Y, Yohn SE, Gilliland K, Loch MT, Schulte ML, Rodriguez AL, Blobaum AL, Niswender CM, Conn PJ, Lindsley CW..  (2019)  Further exploration of an N-aryl phenoxyethoxy pyridinone-based series of mGlu3 NAMs: Challenging SAR, enantiospecific activity and in vivo efficacy.,  29  (18): [PMID:31358468] [10.1016/j.bmcl.2019.07.030]

Source